Pasinex Announces Filing of 2024 Second Quarter Financial Results
August 29, 2024 07:59 ET
|
Pasinex Resources Limited
Pasinex Resources Limited has filed its financial statements, management's discussion and analysis, and related certifications for the three and six months
Rivalry Reports Second Quarter 2024 Results; Rivalry Token Drives $1.7 Million in Additional Revenue, Accelerating Crypto Expansion Efforts in the Third Quarter
August 29, 2024 07:00 ET
|
Rivalry Corp.
Rivalry Reports Second Quarter 2024 Results
XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism
August 29, 2024 07:00 ET
|
XORTX Therapeutics Inc.
● Xanthine oxidase reported to modulate progression of chronic kidney disease, diabetic kidney disease, polycystic kidney disease, and other indications ● CALGARY, Alberta, Aug. 29, 2024 ...
Mikra Ships FOCUS Ahead of Schedule and Prepares for Marketing Push
August 29, 2024 07:00 ET
|
Lifeist Wellness Inc.
Mikra ships Focus preorders ahead of schedule, prepares for September marketing push
Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
August 29, 2024 05:00 ET
|
Medigene AG
Planegg/Martinsried, August 29, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
Hydreight Reports Record Topline¹ Revenue of $5.59M in Q2-2024 (YOY Increase of 27%) and positive Adjusted EBIDTA¹
August 28, 2024 19:32 ET
|
Hydreight Technologies Inc.
“We had another outstanding quarter with record revenue and positive Adjusted EBITDA...Our focus in 2024 is to continue growing revenue, being a profitable company and introducing our story to more...
Avicanna Announces Closing of Non-Brokered Private Placement
August 28, 2024 18:15 ET
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Euro Manganese Submits Application for Strategic Project Status under EU’s Critical Raw Materials Act
August 28, 2024 17:40 ET
|
Euro Manganese Inc.
HIGHLIGHTS Submitted application to designate Chvaletice Manganese Project as a Strategic Project under the EU’s Critical Raw Materials Act (CRMA)CRMA is designed to sustainably ensure availability...
Partnerschaft für Begleitdiagnostika für chronische Krankheiten: QIAGEN weitet Anwendung von QIAstat-Dx auf die Präzisionsmedizin aus
August 28, 2024 16:05 ET
|
QIAGEN N.V.
Neue Vereinbarung erweitert die Zusammenarbeit mit AstraZeneca über die Onkologie hinaus - einschließlich komplexer chronischer Erkrankungen // QIAGENs syndromische Testplattform QIAstat-Dx ermöglicht...
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases
August 28, 2024 16:05 ET
|
QIAGEN N.V.
Venlo, the Netherlands, Aug. 28, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its Master Collaboration Agreement with AstraZeneca to...